The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

A Case of Spontaneous Hemoperitoneum Presenting as the Initial Manifestation of Systemic Lupus Erythematosus

  • Seong, Sang-Seokg (Department of Internal Medicine, Konyang University College of Medicine) ;
  • Joung, Chung-Il (Department of Internal Medicine, Konyang University College of Medicine)
  • Received : 2007.12.28
  • Accepted : 2008.03.28
  • Published : 2010.12.01
⟨ Previous Next ⟩

Abstract

Thrombocytopenia is included in the classification criteria for systemic lupus erythematosus (SLE). However, severe thrombocytopenia causing spontaneous bleeding is rare. Here, we describe a 22-year-old woman who presented with spontaneous hemoperitoneum as the first manifestation of SLE. Laboratory findings compatible with SLE included positive antinuclear antibody and a false-positive venereal disease research laboratory. Symptoms suggesting the disease were not prominent early after admission, but headache and seizures that developed on the 3rd day of admission led to the diagnosis of SLE. The brain magnetic resonance imaging and angiography findings were compatible with the neuropsychiatric manifestations of SLE. High-dose steroid and monthly intravenous cyclophosphamide pulse therapy were effective at improving the headache and seizure, as well as the hemoperitoneum.

Keywords

References

  1. Hahn BH. Systemic lupus erythematosus. In: Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill, 2005:1960-1967.
  2. Mestanza-Peralta M, Ariza-Ariza R, Cardiel MH, Alcocer-Varela J. Thrombocytopenic purpura as initial manifestation of systemic lupus erythematosus. J Rheumatol 1997;24:867-870.
  3. Wallace DJ. Severe lupus. In: Hochberg MC, Silman AJ, Weisman MH, Weinblatt ME, Smolen JS, eds. Rheumatology. 3rd ed. Edinburgh: Mosby, 2003:1419-1425.
  4. Karpatkin S. Autoimmune thrombocytopenic purpura. Semin Hematol 1985;22:260-288.
  5. The American College of Rheumatology nomenclat-ure and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608. https://doi.org/10.1002/1529-0131(199904)42:4<599::AID-ANR2>3.0.CO;2-F
  6. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
  7. Barile-Fabris L, Ariza-Andraca R, Olguin-Ortega L, et al. Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus. Ann Rheum Dis 2005;64:620-625. https://doi.org/10.1136/ard.2004.025528
  8. Boumpas DT, Barez S, Klippel JH, Balow JE. Intermittent cyclophosphamide for the treatment of autoimmune thrombocytopenia in systemic lupus erythematosus. Ann Intern Med 1990;112:674-677. https://doi.org/10.7326/0003-4819-112-9-674
  9. Hallatt JG, Steele CH Jr, Snyder M. Ruptured corpus luteum with hemoperitoneum: a study of 173 surgical cases. Am J Obstet Gynecol 1984;149:5-9. https://doi.org/10.1016/0002-9378(84)90282-5
  10. Castro-Lizano N, Calleja C, Galindo-Rodriguez G, Avina-Zubieta JA. Ovarian haemorrhage, rupture and haemoperitoneum secondary to thrombocy-topenia in a patient with SLE. Lupus 2003;12:648-650. https://doi.org/10.1191/0961203303lu428xx

Cited by

  1. Spontaneous bleeding in systemic lupus erythematosus: Endovascular treatment of two rare cases vol.15, pp.7, 2020, https://doi.org/10.1016/j.radcr.2020.04.010